Differences Between Mefenamic Acid and Tranexamic Acid
Mefenamic acid and tranexamic acid are fundamentally different medications with distinct mechanisms of action, indications, and side effect profiles - mefenamic acid is an NSAID that inhibits prostaglandin synthesis while tranexamic acid is an antifibrinolytic agent that prevents fibrin degradation.
Mechanism of Action
Mefenamic Acid
- Classification: Nonsteroidal Anti-Inflammatory Drug (NSAID)
- Mechanism: Inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis 1
- Primary action: Anti-inflammatory, analgesic, and antipyretic effects through decreased prostaglandin production in peripheral tissues
Tranexamic Acid
- Classification: Antifibrinolytic agent
- Mechanism: Synthetic lysine derivative that inhibits plasminogen activation, thereby inhibiting fibrinolysis 2, 3
- Primary action: Prevents dissolution of fibrin clots by blocking lysine-binding sites on plasminogen molecules 4
Clinical Uses
Mefenamic Acid
- Management of mild to moderate pain
- Treatment of heavy menstrual bleeding (menorrhagia) 5
- Short-term treatment (5-7 days) of bleeding irregularities with copper IUDs 5
- Anti-inflammatory uses for various conditions
Tranexamic Acid
- Reduction of bleeding in surgical settings (cardiac, major non-cardiac surgery) 2
- Management of major trauma and postpartum hemorrhage 2, 3
- Treatment of heavy menstrual bleeding 6
- Management of upper gastrointestinal bleeding 7
- Used in traumatic hyphema and hereditary angioneurotic edema 8
Efficacy Comparison
In menorrhagia treatment:
- Tranexamic acid reduces menstrual blood loss by 34-59% 6
- Tranexamic acid is more effective than mefenamic acid in reducing menstrual blood loss 8, 6
- In a direct comparison study, tranexamic acid reduced menstrual blood loss significantly more than mefenamic acid at clinically relevant dosages 6
Safety and Side Effects
Mefenamic Acid
- Typical NSAID side effects: gastrointestinal disturbances, risk of ulceration
- May accumulate in patients with renal or hepatic failure 1
- No significant thrombotic risk
Tranexamic Acid
- Generally well tolerated with most adverse events being mild to moderate 8
- Common side effects: nausea and diarrhea 7
- Should be used with caution in:
- Patients with massive hematuria (risk of ureteric obstruction)
- Patients on oral contraceptive pills (increased thrombosis risk) 2, 9
- Contraindicated in disseminated intravascular coagulation 2
- Contraindicated when combined with certain hormonal contraceptives like drospirenone due to synergistic prothrombotic effects 9
Pharmacokinetics
Mefenamic Acid
- Rapidly absorbed after oral administration
- Peak plasma levels reached in 2-4 hours
- Elimination half-life approximately 2 hours
- Highly protein-bound (>90% to albumin)
- Metabolized by CYP2C9 enzyme 1
Tranexamic Acid
- Distributed throughout all tissues
- Plasma half-life of 120 minutes
- Primarily excreted renally 3, 4
- Dosing must be adjusted in renal impairment 3
Clinical Decision Making
When choosing between these medications:
- For bleeding associated with inflammation or pain: Consider mefenamic acid
- For significant bleeding where fibrinolysis is a concern: Consider tranexamic acid
- For heavy menstrual bleeding: Tranexamic acid is more effective 6
- For patients with risk factors for thrombosis: Avoid tranexamic acid or use with caution
- For patients with renal impairment: Use either with caution and appropriate dose adjustment
Important Considerations
- Tranexamic acid should not be combined with certain hormonal contraceptives due to increased thrombotic risk 9
- Mefenamic acid is typically used for shorter durations (5-7 days) 5
- Tranexamic acid has shown no increased risk of thromboembolic complications in large meta-analyses 2
Remember that these medications are not interchangeable due to their different mechanisms of action and should be selected based on the specific clinical scenario and patient characteristics.